GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - May 16, 2000JAMC - le 16 mai 2000

Corrections to the Compendium of Pharmaceuticals and Specialties, 35th edition, 2000

CMAJ 2000;162:1405

This is to inform you of 2 corrections in the product recognition section of the 35th edition of the Compendium of Pharmaceuticals and Specialties (CPS).1 On page R22, the photographs for Merck Frosst Canada & Co. products Singulair (montelukast sodium) 5 mg and Singulair (montelukast sodium) 10 mg were inverted. For further information, please refer to the product monograph for Singulair (montelukast sodium) on page 1464 of the CPS.

On page R10, the photograph of Bayer Inc. Consumer Care Division product Aspirin (ASA) 325 mg tablet was replaced by Aspirin (ASA) 325 mg caplet. For further information, please refer to the product monograph for Aspirin (ASA) on page 144 of the CPS.

We apologize for any inconvenience these errors may have caused our users.

Louise Welbanks
Acting Editor-in-Chief
Canadian Pharmacists Association
Ottawa, Ont.

Reference
  1. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties. 35th ed. Ottawa: The Association; 2000.

© 2000 Canadian Medical Association or its licensors